OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
Liqin Yao, Junfeng Chen, Wenxue Ma
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Liqin Yao, Junfeng Chen, Wenxue Ma
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Showing 7 citing articles:
Molecular Basis of Breast Tumor Heterogeneity
Esra Dikoglu, Fresia Pareja
Advances in experimental medicine and biology (2025), pp. 237-257
Closed Access | Times Cited: 1
Esra Dikoglu, Fresia Pareja
Advances in experimental medicine and biology (2025), pp. 237-257
Closed Access | Times Cited: 1
Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer
Khalil Saleh, Rita Khoury, Nadine Khalife, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 6
Khalil Saleh, Rita Khoury, Nadine Khalife, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 6
Trophoblast Cell Surface Antigen Imprinted Polymer Nanoparticles for Breast Cancer Therapy
Lila Louadj, Perla Benghouzi, Romain Morichon, et al.
ACS Applied Nano Materials (2025) Vol. 8, Iss. 1, pp. 329-339
Closed Access
Lila Louadj, Perla Benghouzi, Romain Morichon, et al.
ACS Applied Nano Materials (2025) Vol. 8, Iss. 1, pp. 329-339
Closed Access
Advances in Trop-2 targeted antibody-drug conjugates for breast cancer: mechanisms, clinical applications, and future directions
Yujun Tong, Xiaobing Fan, Huan Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Yujun Tong, Xiaobing Fan, Huan Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
[99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
Yining Sun, Zhixin Hao, Hannan Gao, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268564-jnumed.124.268564
Closed Access
Yining Sun, Zhixin Hao, Hannan Gao, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268564-jnumed.124.268564
Closed Access
Sacituzumab govitecan in triple-negative breast cancer: from bench to bedside, and back
Valentina Rossi, Alessandra Turati, Antonio Rosato, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Valentina Rossi, Alessandra Turati, Antonio Rosato, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Mechanisms of resistance of antibody-drug conjugates—Obstacles to overcome
Yanitsa Davidkova, Milan Jagurinoski, Margarita Guenova
Elsevier eBooks (2024), pp. 257-273
Closed Access
Yanitsa Davidkova, Milan Jagurinoski, Margarita Guenova
Elsevier eBooks (2024), pp. 257-273
Closed Access
